Susan Margaret Sundström
Corporate Officer/Principal presso The University of Southampton
Posizioni attive di Susan Margaret Sundström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| The University of Southampton | Corporate Officer/Principal | - | - |
Storia della carriera di Susan Margaret Sundström
Precedenti posizioni note di Susan Margaret Sundström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNAIRGEN PLC | Direttore/Membro del Consiglio | 03/09/2009 | 03/09/2009 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| SYNAIRGEN PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |
